Skip to main content

Table 3 Multivariate analysis of factors predicting clinical remission in response to IFX induction therapy (5 mg/kg)

From: Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience

 

p value

Odds ratio

95% CI

Modified Truelove and Witts severity index

0.27

0.81

0.54–1.20

Negative for cytomegalovirus

0.26

1.08

0.77–19.17

Serum albumin level >35 g/L at IFX initiation

0.27

6.37

0.21–190.12

Serum CRP level at IFX initiation

0.64

1.08

0.78–1.49

Serum CRP level <5 mg/L at 2 weeks after IFX initiation

0.08

8.86

0.59–132.23

  1. IFX: infliximab, IM: immunomodulator, CRP: C-reactive protein, CI: confidence interval.
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us